We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Induction Healthcare Group Plc | LSE:INHC | London | Ordinary Share | GB00BJ0M3545 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.50 | 11.00 | 14.00 | 12.50 | 12.50 | 12.50 | 187,682 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 12.88M | -17.38M | -0.1882 | -0.66 | 11.55M |
TIDMINHC
RNS Number : 4226M
Induction Healthcare Group PLC
11 January 2023
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Results of 2022 Annual General Meeting ("AGM")
Induction Healthcare (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide , held its AGM today at 50 Liverpool Street, London EC2M 7PY at 9.30am (GMT).
The poll results on each resolution proposed are available on the Company website.
All Ordinary Resolutions were passed. Special Resolutions 8, 9 and 10 did not pass. The Board notes the decision of shareholders in relation to these resolutions and will consult with shareholders to gain further feedback. Even so, the Board remains clear on the need to tightly manage costs and execute a plan ensuring the Group is correctly sized and on target to deliver a cash breakeven position during FY24.
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com Christopher Samler, Executive Chair Paul Tambeau, Chief Operating Officer Singer Capital Markets (Nominated Adviser and Broker) +44 (0)20 7496 3000 Philip Davies Walbrook PR Ltd +44 (0)20 7933 8780 or induction@walbrookpr.com Alice Woodings / Paul McManus Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGEAAFFFENDEFA
(END) Dow Jones Newswires
January 11, 2023 07:52 ET (12:52 GMT)
1 Year Induction Healthcare Chart |
1 Month Induction Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions